Glysens Incorporated

At GlySens®, we are dedicated to advancing the care of individuals with diabetes through the development of a long term, implantable continuous glucose monitoring technology. Since the company’s inception in 1998, we have focused on designing and developing the world’s first truly long term, wireless, implantable, continuous glucose monitor, the Eclipse® ICGM® System. Our goal is to empower individuals with easy, at-a-glance, worry-free diabetes technologies that seamlessly deliver the information they need to optimize care, while freeing them to live life on their own terms. CAUTION – Investigational Device. Limited by Federal law to investigational use.